Gadgeel SM - Search Results

1

Novel combinations using pemetrexed in malignant mesothelioma.

Gadgeel SM, Pass HI. Gadgeel SM, et al. Clin Lung Cancer. 2004 Apr;5 Suppl 2:S61-6. doi: 10.3816/clc.2004.s.005. Clin Lung Cancer. 2004. PMID: 15117427 Review.

2

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.

Hussain M, Gadgeel S, Kucuk O, Du W, Salwen W, Ensley J. Hussain M, et al. Cancer. 1999 Dec 1;86(11):2364-9. Cancer. 1999. PMID: 10590379 Clinical Trial.

3

Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer.

Gadgeel SM, Shields AF, Heilbrun LK, Labadidi S, Zalupski M, Chaplen R, Philip PA. Gadgeel SM, et al. Am J Clin Oncol. 2003 Feb;26(1):37-41. doi: 10.1097/00000421-200302000-00008. Am J Clin Oncol. 2003. PMID: 12576922 Clinical Trial.

4

Phase I study of bryostatin 1 and gemcitabine.

El-Rayes BF, Gadgeel S, Shields AF, Manza S, Lorusso P, Philip PA. El-Rayes BF, et al. Clin Cancer Res. 2006 Dec 1;12(23):7059-62. doi: 10.1158/1078-0432.CCR-06-1419. Clin Cancer Res. 2006. PMID: 17145828 Clinical Trial.

5

Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer.

Wozniak AJ, Belzer K, Heilbrun LK, Kucuk O, Gadgeel S, Kalemkerian GP, Venkatramanamoorthy R, Kraut MJ. Wozniak AJ, et al. Clin Lung Cancer. 2007 Mar;8(5):313-8. doi: 10.3816/CLC.2007.n.010. Clin Lung Cancer. 2007. PMID: 17562230 Clinical Trial.

6

Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.

Simon GR, Verschraegen CF, Jänne PA, Langer CJ, Dowlati A, Gadgeel SM, Kelly K, Kalemkerian GP, Traynor AM, Peng G, Gill J, Obasaju CK, Kindler HL. Simon GR, et al. Among authors: gadgeel sm. J Clin Oncol. 2008 Jul 20;26(21):3567-72. doi: 10.1200/JCO.2007.15.2868. J Clin Oncol. 2008. PMID: 18640937 Clinical Trial.

7

Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.

Gadgeel SM, Wozniak A, Ruckdeschel JC, Heilbrun LK, Venkatramanamoorthy R, Chaplen RA, Kraut MJ, Kalemkerian GP. Gadgeel SM, et al. J Thorac Oncol. 2008 Nov;3(11):1293-300. doi: 10.1097/JTO.0b013e31818b194e. J Thorac Oncol. 2008. PMID: 18978565 Free PMC article. Clinical Trial.

8

Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines.

Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH. Gadgeel SM, et al. Cancer. 2009 May 15;115(10):2165-76. doi: 10.1002/cncr.24250. Cancer. 2009. Retraction in: Cancer. 2016 Oct 15;122(20):3248. doi: 10.1002/cncr.30218 PMID: 19288574 Free article. Retracted.

9

Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States.

Gadgeel SM, Harlan LC, Zeruto CA, Osswald M, Schwartz AG. Gadgeel SM, et al. Cancer. 2009 Jun 15;115(12):2744-54. doi: 10.1002/cncr.24307. Cancer. 2009. PMID: 19396819 Free PMC article.

10

Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung cancer.

Gadgeel SM, Ruckdeschel JC, Patel BB, Wozniak A, Konski A, Valdivieso M, Hackstock D, Chen W, Belzer K, Burger AM, Marquette L, Turrisi A. Gadgeel SM, et al. J Thorac Oncol. 2011 May;6(5):927-33. doi: 10.1097/JTO.0b013e3182156109. J Thorac Oncol. 2011. PMID: 21415776 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters